Profile data is unavailable for this security.
About the company
Ascentage Pharma Group International is an investment holding company principally engaged in developing novel small therapies for cancers, hepatitis B virus (HBV) and certain age-related diseases. The Company focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis, or programmed cell death. The Company's main products include the next-generation kinase inhibitor: HQP1351 and apoptosis targeted drugs APG-1252, APG2575, APG-115 and so on. The Company conducts businesses within the domestic market and to overseas markets, including the United States.
- Revenue in HKD (TTM)239.92m
- Net income in HKD-1.00bn
- Incorporated2017
- Employees583.00
- LocationAscentage Pharma Group International218 Xinghu StreetBuilding B7, 7th FloorSuzhou ChinaCHN
- Websitehttps://www.ascentage.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biocytogen Pharmaceuticals Beijng Co Ltd | 774.85m | -413.90m | 3.09bn | 1.07k | -- | 3.63 | -- | 3.98 | -1.04 | -1.04 | 1.95 | 2.13 | 0.2732 | 16.21 | 5.73 | 726,876.80 | -14.59 | -- | -18.88 | -- | 70.59 | -- | -53.42 | -- | 1.24 | -19.44 | 0.4077 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
| CK Life Sciences Intl (Holdings) Inc | 5.32bn | 17.25m | 3.27bn | 1.93k | 189.94 | 0.78 | 28.82 | 0.6139 | 0.0018 | 0.0018 | 0.5538 | 0.4359 | 0.4728 | 2.96 | 4.74 | 2,755,038.00 | 0.1532 | 1.11 | 0.211 | 1.43 | 30.76 | 30.52 | 0.3241 | 2.42 | 0.8512 | 0.8796 | 0.5861 | 59.00 | 0.8936 | 0.3407 | -86.93 | -42.01 | 0.2784 | -- |
| China Isotope & Radiation Corp | 7.17bn | 400.95m | 3.29bn | 3.11k | 8.20 | 0.6483 | 2.94 | 0.4585 | 1.25 | 1.25 | 22.42 | 15.86 | 0.5312 | 4.22 | 1.79 | 2,309,569.00 | 6.21 | 6.57 | 12.82 | 13.26 | 52.48 | 59.89 | 11.70 | 12.62 | 1.73 | -- | 0.1919 | 6.88 | 7.82 | 15.35 | -5.43 | 2.88 | -- | 2.92 |
| Ocumension Therapeutics | 266.28m | -410.48m | 4.17bn | 444.00 | -- | 1.31 | -- | 15.67 | -0.6374 | -0.6374 | 0.4137 | 4.57 | 0.078 | 3.61 | 2.12 | 599,724.40 | -12.03 | -38.78 | -13.21 | -41.47 | 58.60 | 62.30 | -154.16 | -975.82 | 3.72 | -- | 0.0451 | -- | 54.99 | -- | 5.68 | -- | -- | -- |
| Alphamab Oncology | 236.45m | -227.61m | 4.29bn | 435.00 | -- | 2.38 | -- | 18.16 | -0.2367 | -0.2367 | 0.2463 | 1.87 | 0.1028 | 0.7705 | 19.34 | 543,573.90 | -9.90 | -18.72 | -11.69 | -21.94 | 74.75 | -- | -96.26 | -415.55 | 5.55 | -- | 0.1333 | -- | 31.12 | -- | 35.35 | -- | -- | -- |
| Jiangsu Recbio Technology Co Ltd | 0.00 | -618.18m | 4.41bn | 472.00 | -- | 3.78 | -- | -- | -1.29 | -1.29 | 0.00 | 2.42 | 0.00 | -- | -- | 0.00 | -25.47 | -- | -30.68 | -- | -- | -- | -- | -- | 2.33 | -- | 0.378 | -- | -- | -- | 20.86 | -- | -- | -- |
| Consun Pharmaceutical Group Ltd | 2.80bn | 847.94m | 4.64bn | 3.13k | 5.39 | 1.18 | 4.97 | 1.66 | 1.06 | 1.06 | 3.50 | 4.83 | 0.4981 | 2.08 | 9.10 | 895,247.90 | 15.13 | 12.04 | 22.57 | 19.25 | 74.19 | 74.55 | 30.37 | 24.89 | 2.62 | -- | 0.1155 | 41.53 | 10.71 | 7.03 | 14.88 | 11.01 | -- | 18.43 |
| Ascentage Pharma Group International | 239.92m | -1.00bn | 5.02bn | 583.00 | -- | 76.88 | -- | 20.93 | -3.53 | -3.53 | 0.8499 | 0.225 | 0.0833 | 2.38 | 2.22 | 411,533.60 | -34.73 | -44.93 | -52.82 | -57.04 | 86.24 | 87.68 | -417.02 | -976.10 | 1.42 | -15.03 | 0.9622 | -- | 5.85 | 100.76 | -4.84 | -- | 2.82 | -- |
| Sihuan Pharmaceutical Holdings Group Ltd | 2.01bn | -58.38m | 5.04bn | 2.87k | -- | 1.05 | 116,536.80 | 2.51 | -0.0063 | -0.0063 | 0.2163 | 0.5134 | 0.1572 | 0.8657 | 2.35 | 700,174.90 | -2.18 | -6.85 | -3.34 | -9.10 | 69.64 | 75.81 | -13.85 | -36.23 | 1.37 | -0.5119 | 0.1863 | -- | -14.70 | -8.60 | 97.23 | -- | -- | -- |
| Shandong Boan Biotechnology Co Ltd | 668.08m | -129.02m | 5.04bn | 745.00 | -- | 3.53 | -- | 7.55 | -0.2533 | -0.2533 | 1.31 | 2.80 | 0.2732 | 1.35 | 2.53 | -- | -5.28 | -- | -7.02 | -- | 66.16 | -- | -19.31 | -- | 0.8383 | -7.47 | 0.2352 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -269.50m | 5.26bn | 133.00 | -- | 4.77 | -- | -- | -1.35 | -1.35 | 0.00 | 5.45 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 6.41 | -- | 0.0185 | -- | -- | -- | 65.62 | -- | -- | -- |
| Microport NeuroTech Ltd | -100.00bn | -100.00bn | 5.28bn | 571.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 21.61 | -- | 768.73 | -- | -- | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | -100.00bn | -100.00bn | 5.59bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -28.25 | -- | 5.82 | -- | -- | -- |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 919.49m | 117.41m | 6.30bn | 948.00 | 18.58 | 0.8624 | -- | 6.85 | 0.1141 | 0.1141 | 0.8748 | 2.46 | 0.2907 | 1.81 | 1.79 | 969,922.90 | 3.71 | 7.03 | 4.64 | 9.05 | 91.06 | 92.17 | 12.75 | 17.26 | 3.62 | 151.72 | 0.0073 | 39.16 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | 0.00 |
| Tong Ren Tang Technologies Co Ltd | 7.32bn | 637.89m | 6.31bn | 4.10k | 9.90 | 0.848 | 4.61 | 0.8625 | 0.498 | 0.498 | 5.72 | 5.81 | 0.5212 | 0.9835 | 5.68 | 1,785,144.00 | 7.64 | 7.68 | 12.10 | 12.32 | 42.04 | 43.50 | 14.65 | 16.11 | 2.37 | -- | 0.1443 | 39.94 | 13.04 | 6.01 | 1.25 | -2.73 | -22.26 | 0.0178 |
| New Horizon Health Ltd | 1.47bn | 119.56m | 6.47bn | 1.04k | 59.10 | 2.00 | 41.57 | 4.40 | 0.2392 | 0.2392 | 3.22 | 7.05 | 0.4536 | 2.16 | 2.08 | 1,676,600.00 | 3.67 | -- | 3.99 | -- | 88.74 | -- | 8.10 | -- | 10.50 | -- | 0.1305 | -- | 259.54 | -- | 97.40 | -- | -- | -- |
Data as of May 03 2024. Currency figures normalised to Ascentage Pharma Group International's reporting currency: Hong Kong Dollar HKD
6.99%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 05 Apr 2024 | 6.47m | 2.23% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2023 | 4.59m | 1.58% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 3.07m | 1.06% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2023 | 1.72m | 0.59% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 1.44m | 0.50% |
| E Fund Management Co., Ltd.as of 30 Jun 2023 | 900.40k | 0.31% |
| BlackRock Advisors (UK) Ltd.as of 02 Apr 2024 | 804.10k | 0.28% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 458.80k | 0.16% |
| SSgA Funds Management, Inc.as of 04 Apr 2024 | 434.82k | 0.15% |
| Caitong Fund Management Co., Ltd.as of 30 Jun 2023 | 415.00k | 0.14% |
More ▼
Data from 30 Jun 2023 - 22 Apr 2024Source: FactSet Research Systems Inc.
